Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer DOI Creative Commons
Yang Chen,

Sujuan Yang,

Jena Tavormina

et al.

Cancer Cell, Journal Year: 2022, Volume and Issue: 40(8), P. 818 - 834.e9

Published: July 21, 2022

Language: Английский

Hallmarks of Cancer: New Dimensions DOI Open Access
Douglas Hanahan

Cancer Discovery, Journal Year: 2022, Volume and Issue: 12(1), P. 31 - 46

Published: Jan. 1, 2022

The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity phenotypes and genotypes into provisional set underlying principles. As knowledge mechanisms has progressed, other facets disease have emerged as potential refinements. Herein, prospect raised that phenotypic plasticity disrupted differentiation discrete hallmark capability, nonmutational epigenetic reprogramming polymorphic microbiomes both constitute distinctive enabling characteristics facilitate acquisition capabilities. Additionally, senescent cells, varying origins, may be added to roster functionally important cell types in tumor microenvironment. SIGNIFICANCE: Cancer daunting breadth scope its diversity, spanning genetics, tissue biology, pathology, response therapy. Ever more powerful experimental computational tools technologies are providing an avalanche "big data" about myriad manifestations diseases encompasses. integrative concept embodied helping distill this increasingly logical science, new dimensions presented perspective add value endeavor, fully understand development malignant progression, apply medicine.

Language: Английский

Citations

3364

Systemic immunity in cancer DOI Open Access
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer

et al.

Nature reviews. Cancer, Journal Year: 2021, Volume and Issue: 21(6), P. 345 - 359

Published: April 9, 2021

Language: Английский

Citations

1014

The microbiome and human cancer DOI
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman

et al.

Science, Journal Year: 2021, Volume and Issue: 371(6536)

Published: March 25, 2021

Microbial roles in cancer formation, diagnosis, prognosis, and treatment have been disputed for centuries. Recent studies provocatively claimed that bacteria, viruses, and/or fungi are pervasive among cancers, key actors immunotherapy, engineerable to treat metastases. Despite these findings, the number of microbes known directly cause carcinogenesis remains small. Critically evaluating building frameworks such evidence light modern biology is an important task. In this Review, we delineate between causal complicit trace common themes their influence through host's immune system, herein defined as immuno-oncology-microbiome axis. We further review intratumoral approaches manipulate gut or tumor microbiome while projecting next phase experimental discovery.

Language: Английский

Citations

904

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms DOI
Patrice D. Cani, Clara Depommier, Muriel Derrien

et al.

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2022, Volume and Issue: 19(10), P. 625 - 637

Published: May 31, 2022

Language: Английский

Citations

661

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer DOI Creative Commons
Maik Luu, Zeno Riester,

Adrian Baldrich

et al.

Nature Communications, Journal Year: 2021, Volume and Issue: 12(1)

Published: July 1, 2021

Abstract Emerging data demonstrate that the activity of immune cells can be modulated by microbial molecules. Here, we show short-chain fatty acids (SCFAs) pentanoate and butyrate enhance anti-tumor cytotoxic T lymphocytes (CTLs) chimeric antigen receptor (CAR) through metabolic epigenetic reprograming. We in vitro treatment CTLs CAR with increases function mTOR as a central cellular sensor, inhibits class I histone deacetylase activity. This reprogramming results elevated production effector molecules such CD25, IFN-γ TNF-α, significantly enhances antigen-specific ROR1-targeting syngeneic murine melanoma pancreatic cancer models. Our shed light onto may used for enhancing immunity. Collectively, identify two SCFAs therapeutic utility context immunotherapy.

Language: Английский

Citations

425

Cancer stem cell–immune cell crosstalk in tumour progression DOI
Defne Bayık, Justin D. Lathia

Nature reviews. Cancer, Journal Year: 2021, Volume and Issue: 21(8), P. 526 - 536

Published: June 8, 2021

Language: Английский

Citations

394

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment DOI Creative Commons
Khiem C. Lam, Romina E. Araya, April Huang

et al.

Cell, Journal Year: 2021, Volume and Issue: 184(21), P. 5338 - 5356.e21

Published: Oct. 1, 2021

Language: Английский

Citations

393

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery DOI Creative Commons
Jun Zhou,

Maoyi Li,

Qiufang Chen

et al.

Nature Communications, Journal Year: 2022, Volume and Issue: 13(1)

Published: June 14, 2022

Abstract Reactive oxygen species (ROS) play vital roles in intestinal inflammation. Therefore, eliminating ROS the inflammatory site by antioxidant enzymes such as catalase and superoxide dismutase may effectively curb bowel disease (IBD). Here, Escherichia coli Nissle 1917 (ECN), a kind of oral probiotic, was genetically engineered to overexpress (ECN-pE) for treatment To improve bioavailability ECN-pE gastrointestinal tract, chitosan sodium alginate, effective biofilms, were used coat via layer-by-layer electrostatic self-assembly strategy. In mouse IBD model induced different chemical drugs, chitosan/sodium alginate coating (ECN-pE(C/A) 2 ) relieved inflammation repaired epithelial barriers colon. Unexpectedly, EcN-pE(C/A) could also regulate microbial communities abundance Lachnospiraceae _NK4A136 Odoribacter flora, which are important microbes maintain homeostasis. Thus, this study lays foundation development living therapeutic proteins using probiotics treat intestinal-related diseases.

Language: Английский

Citations

390

Microbiome and cancer DOI Creative Commons
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman

et al.

Cancer Cell, Journal Year: 2021, Volume and Issue: 39(10), P. 1317 - 1341

Published: Sept. 9, 2021

Language: Английский

Citations

380

Targeting the gut and tumor microbiota in cancer DOI
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani

et al.

Nature Medicine, Journal Year: 2022, Volume and Issue: 28(4), P. 690 - 703

Published: April 1, 2022

Language: Английский

Citations

336